Article Text

other Versions

PDF
Transient elastography predicts fibrosis progression in patients with recurrent hepatitis c after liver transplantation
  1. Cristina Rigamonti (crigamo{at}tin.it)
  1. Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena and University of Milan, Italy
    1. Maria F Donato (francesca.donato{at}policlinico.mi.it)
    1. Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena and University of Milan, Italy
      1. Mirella Fraquelli (mfraquelli{at}yahoo.it)
      1. Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena and University of Milan, Italy
        1. Francesca Agnelli
        1. Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena and University of Milan, Italy
          1. Guido Ronchi
          1. Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena and University of Milan, Italy
            1. Giovanni Casazza
            1. Istituto di Statistica Medica e Biometria, University of Milan, Italy
              1. Giorgio Rossi
              1. Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena and University of Milan, Italy
                1. Massimo Colombo
                1. Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena and University of Milan, Italy

                  Abstract

                  Objective: Transient elastography (TE) allows non-invasive evaluation of liver disease severity in patients with chronic hepatitis C. This procedure, however, warrants further validation in the setting of liver transplantation (LT), including patients under follow-up for recurrent hepatitis C.

                  Setting: Tertiary referral hospital. Patients: 95 patients (75 males) transplanted for end-stage liver disease due to hepatitis C virus. Interventions: Paired liver biopsy (LB) and TE were carried out 6 to 156 (median 35) months after LT. 40 patients with recurrent hepatitis C sequentially evaluated 6 to 21 months apart.

                  Main outcome measures: Clinical, laboratory and graft histological features influencing TE results.

                  Results: Median TE values were 7.6 kPa in the 90 patients with a successful TE examination, being 5.6 kPa in the 30 patients with Ishak fibrosis score (S) of 0-1, 7.6 kPa in the 38 with S2-3; 16.7 kPa in the 22 with S4-6, (p<0.0001). The areas under ROC curves were 0.85 (95%CI: 0.76-0.92) for S≥3, 0.90 (95%CI: 0.82-0.95) for S≥4 with 7.9 and 11.9 kPa optimal TE cut-off (81% and 82% sensitivity, 88% and 94% negative predictive value, respectively). Fibrosis, necroinflammatory activity and higher than 200 IU/L gamma-glutamyl transpeptidase levels independently influenced TE results. During post-LT follow-up, TE results changed in parallel with grading (r=0.63) and staging (r=0.71), showing 86% sensitivity and 92% specificity in predicting staging increases.

                  Conclusions: TE accurately predicts fibrosis progression in LT patients with recurrent hepatitis C, suggesting that protocol LB might be avoided in patients with improved or stable TE values during follow-up.

                  • graft disease
                  • hepatitis C recurrence
                  • liver biopsy
                  • liver transplantation
                  • transient elastography

                  Statistics from Altmetric.com

                  Request permissions

                  If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

                  Linked Articles

                  • Digest
                    Robin Spiller Magnus Simren